Foundation Medicine buying Saga Dx and its MRD test for $595M
Nearly a year after the first U.S. commercial launch of the multicancer molecular residual disease (MRD) detection platform…
Roche plots route to EMA approval for DMD gene therapy
To read the full story, subscribe or sign in. April 17, 2026 By Nuala Moran No Comments Roche…
Roche secures CE mark for blood test to identify ApoE4 carriers
Roche Holding AG received CE Mark approval for its Elecsys Apolipoprotein E4 (ApoE4) biomarker test, an in vitro…
Roche to invest ₩710B in South Korea over five years
Roche Holding AG pledged to invest ₩710 billion (US$484.6 million) in South Korea over the next five years,…
Roche to invest ₩710B in South Korea over five years
Roche Holding AG pledged to invest ₩710 billion (US$484.6 million) in South Korea over the next five years,…
Qyuns and Roche partner in $1B+ bispecific antibody deal
To read the full story, subscribe or sign in. Oct. 29, 2025 By Marian (YoonJee) Chu No Comments…
Qyuns and Roche partner in $1B+ bispecific antibody deal
To read the full story, subscribe or sign in. Nov. 4, 2025 By Marian (YoonJee) Chu No Comments…
Still no scare for Ohtuvayre: Roche IL-33 COPD data mixed
The fate of IL-33-targeting astegolimab will be determined by talks with regulators, after Roche AG’s Genentech unit rolled…
Jazz-Roche lung cancer combo approved by FDA
The U.S. FDA has approved the priority sNDA for a new first-line maintenance therapy in extensive-stage small-cell lung…
Roche follows other pharmas, committing $50B in US investment
Roche AG has become the latest pharmaceutical company to respond to the Trump administration’s threat to impose tariffs,…
MASH dash speeds up as Roche acquires 89bio for up to $3.5B
The dash for MASH is gaining momentum, with Roche AG acquiring 89bio Inc. and its phase III FGF21…
CERAN wrap: Roche phase III BC win seals thesis, boosts Olema
Roche AG’s Genentech unit landed another clinical victory with giredestrant that provided a major stock boost for competitor…